LI Long-yun, WANG Bin-chao. Single-Agent Pemetremed or Sequential Pemetrexed/Gemcitabine as Front-Line Treatment of Advanced Non-Small Cell Lung Cancer in Elderly Patients or Patients Ineligible for Platinum-Based Chemotherapy: A Multicenter, Randomized, Phase Ⅱ Trial[J]. Journal of Evidence-Based Medicine, 2007, 7(5): 263-266. DOI: 10.3969/j.issn.1671-5144.2007.05.003
|
Citation:
|
LI Long-yun, WANG Bin-chao. Single-Agent Pemetremed or Sequential Pemetrexed/Gemcitabine as Front-Line Treatment of Advanced Non-Small Cell Lung Cancer in Elderly Patients or Patients Ineligible for Platinum-Based Chemotherapy: A Multicenter, Randomized, Phase Ⅱ Trial[J]. Journal of Evidence-Based Medicine, 2007, 7(5): 263-266. DOI: 10.3969/j.issn.1671-5144.2007.05.003
|
LI Long-yun, WANG Bin-chao. Single-Agent Pemetremed or Sequential Pemetrexed/Gemcitabine as Front-Line Treatment of Advanced Non-Small Cell Lung Cancer in Elderly Patients or Patients Ineligible for Platinum-Based Chemotherapy: A Multicenter, Randomized, Phase Ⅱ Trial[J]. Journal of Evidence-Based Medicine, 2007, 7(5): 263-266. DOI: 10.3969/j.issn.1671-5144.2007.05.003
|
Citation:
|
LI Long-yun, WANG Bin-chao. Single-Agent Pemetremed or Sequential Pemetrexed/Gemcitabine as Front-Line Treatment of Advanced Non-Small Cell Lung Cancer in Elderly Patients or Patients Ineligible for Platinum-Based Chemotherapy: A Multicenter, Randomized, Phase Ⅱ Trial[J]. Journal of Evidence-Based Medicine, 2007, 7(5): 263-266. DOI: 10.3969/j.issn.1671-5144.2007.05.003
|
DownLoad: